-

Milliman analysis: Corporate pension funded status improves by $5 billion in November

Milliman PFI funded ratio rises to 103.5% after market gains offset falling discount rates

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the results of its latest Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans.

During November, the Milliman 100 PFI plans’ funded ratio rose from 103.2% at the end of October to 103.5% as of November 30. Strong monthly investment returns of 1.88% drove this result, lifting the market value of plan assets by $18 billion to $1.338 trillion at month’s end. These gains offset a $13 billion rise in plan liabilities, the result of a 10-basis-point drop in the monthly discount rate, to 5.21% for November.

“November saw the second consecutive month of improvement in the PFI funded ratio, with the 1.88% investment gain more than offsetting the rise in plan liabilities caused by falling discount rates,” said Zorast Wadia, author of the PFI. “Sponsors of plans with calendar-year fiscal years will be watching for further discount rate and financial market movements as we approach the end of 2024.”

Looking ahead, under an optimistic forecast with rising interest rates (reaching 5.86% by the end of 2025 and 6.46% by the end of 2026) and annual asset returns of 10.4%, the funded ratio would reach 117% by the end of 2025 and 131% by the end of 2026. Under a pessimistic forecast with similar interest rate and asset movements (4.56% discount rate at the end of 2025 and 3.96% by the end of 2026 and 2.4% annual asset returns), the funded ratio would drop to 93% by the end of 2025 and 85% by the end of 2026.

To view the complete Pension Funding Index, go to www.milliman.com/pfi. To see Milliman’s full range of annual Pension Funding Studies, go to https://www.milliman.com/en/retirement-and-benefits/pension-funding-studies. To receive regular updates of Milliman’s pension funding analysis, contact us at pensionfunding@milliman.com.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges—from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

Milliman, Inc.


Release Versions

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

More News From Milliman, Inc.

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom